AngioDynamics, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from AngioDynamics, Inc.'s yearly results (2023–2026), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-2.7×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Higher than 59% of Healthcare companies in United States.
Cash Locked Ratio
$22For every $100 of sales, $22 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $20 tied up three years earlier.
Less money tied up than 54% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
1/3 · 1/3Sales grew in 1 of the last 3 years; profit grew in 1 of 3.
Less steady than 70% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales fell 5%
Sales fell 5% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-5% / -50%In 3 years sales changed by -5% while total assets changed by -50%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
—Data incomplete
Cash Cushion Ratio
—Data incomplete
Tangible Assets Ratio
75%Of every $100 the company owns, $75 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 57% of Healthcare companies in United States.
Tangible Net Worth Ratio
61%Of every $100 of net worth, $61 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 53% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (11)
AngioDynamics, Inc. made a loss over the last year. AngioDynamics, Inc. owes $0.36 for every $1 it owns. AngioDynamics, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results May 2026.
P/E ratio
LossAngioDynamics, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
2.96The share price is 2.96 times AngioDynamics, Inc.'s book value per share, higher than 55% of Healthcare companies in United States.
Market cap
$505 MThe total market value of all of AngioDynamics, Inc.'s shares at today's price (share price × number of shares), larger than 55% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$171 MWhat AngioDynamics, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 May 2026).
Book value per share
$4.06Net worth divided by the number of shares. The share price of $12.02 is 3.0 times this, which is the P/B above.
Return on equity (ROE)
-19.2%AngioDynamics, Inc. lost 19.2% of its shareholders' money over the last year, higher than 66% of Healthcare companies in United States.
Owes vs Owns
0.36×AngioDynamics, Inc. owes $0.36 for every $1 it owns (low), lower than 54% of Healthcare companies in United States.
Dividend yield
NoneAngioDynamics, Inc. does not currently pay a dividend.
Revenue growth
+9%Revenue rose 9% in the year to May 2026, and shrank 2% a year on average over 3 years.
Profit growth
LossAngioDynamics, Inc. made a loss in each of the last two years.
Profit margin
-11.5%AngioDynamics, Inc. lost $11 for every $100 of revenue.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For AngioDynamics, Inc.: $505 M ÷ $171 M (31 May 2026) = 3.0.
What is AngioDynamics, Inc.'s return on equity?
AngioDynamics, Inc. lost 19.2% of its shareholders' money over the last year, higher than 66% of Healthcare companies in United States.
How much does AngioDynamics, Inc. owe compared with what it owns?
AngioDynamics, Inc. owes $0.36 for every $1 it owns (low), lower than 54% of Healthcare companies in United States.
Does AngioDynamics, Inc. pay a dividend?
No. AngioDynamics, Inc. does not currently pay a dividend.
Is AngioDynamics, Inc.'s revenue growing?
Revenue rose 9% in the year to May 2026, and shrank 2% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.